Let's Start With What NAD+ Actually Is
Nicotinamide adenine dinucleotide. It's a coenzyme — a molecule that sits inside every cell in your body and participates in hundreds of enzymatic reactions. Most critically, it's essential to energy metabolism and DNA repair.
Your mitochondria — the structures responsible for converting nutrients into usable cellular energy — depend on NAD+ to function. As does SIRT1, one of the primary longevity-related proteins in your body. And PARP, an enzyme your cells use to repair DNA damage.
NAD+ declines with age. By the time you're 50, you have roughly half the NAD+ you did at 20. That decline is real, measurable, and clinically relevant.
Why It Became a Phenomenon
The longevity research community — particularly work out of Harvard's Sinclair Lab — put NAD+ precursors on the map in the early 2010s. The findings were striking in animal models: restoring NAD+ levels reversed markers of aging, improved metabolic function, and extended lifespan in mice.
The supplement industry ran with it. NMN and NR (two oral NAD+ precursors) became multi-hundred-million-dollar categories almost overnight.
Then came IV NAD+ clinics. Then intranasal formulations. Then subcutaneous injections.
And here's where it gets complicated — because not all of these delivery methods are equivalent, and the clinical outcomes can vary significantly based on how you're actually getting the molecule into your cells.
What the Research Actually Supports
Human clinical trials on NAD+ are growing but still relatively early. Here's what we can say with reasonable confidence:
Energy and fatigue: There is consistent patient-reported and some trial-supported evidence that NAD+ optimization improves subjective energy and reduces fatigue — particularly in individuals who are genuinely depleted.
Cognitive clarity: Many patients describe improved mental clarity, particularly with IV administration. The mechanism may involve improved mitochondrial function in neurons.
Metabolic function: Preclinical data is strong; human data is building. NAD+ appears to improve insulin sensitivity and mitochondrial efficiency — both relevant to metabolic disease.
DNA repair: This is perhaps the most clinically important application. NAD+ is a substrate for PARP enzymes that repair DNA strand breaks. As we accumulate more oxidative damage with age, this function becomes increasingly critical.
What the research does not yet support: claims that NAD+ supplementation alone will dramatically extend your lifespan, cure neurodegeneration, or replace the need for lifestyle interventions. The molecules are powerful. They're not magic.
The Delivery Problem
Here's the thing that most NAD+ marketing glosses over: oral bioavailability of NAD+ itself is essentially zero. You can't take an NAD+ capsule and expect it to meaningfully raise your cellular NAD+ levels.
What you can do:
NMN or NR (oral precursors): These are converted to NAD+ through a cellular biosynthesis pathway. They work — at the right doses. The data on NMN is slightly stronger, and the sublingual form improves absorption meaningfully over standard capsules. That said, even well-absorbed oral precursors have limits on how much they can raise systemic NAD+.
IV NAD+: This bypasses the absorption problem entirely. Direct infusion raises circulating NAD+ levels substantially. The tradeoff: it requires a clinical setting, takes several hours, and is not a once-and-done intervention. We use IV NAD+ for patients with significant depletion — chronic fatigue, post-viral syndromes, significant metabolic dysfunction.
Subcutaneous NAD+: A newer delivery method that sits between oral and IV in terms of bioavailability. More convenient than IV with better absorption than oral. We're seeing promising results, particularly for maintenance dosing.
Who Actually Benefits Most
Be honest with yourself about this. NAD+ optimization is not a universal necessity at 35. Here's who tends to see the most meaningful response:
- Individuals with documented mitochondrial dysfunction or significant fatigue not explained by other causes
- Those with high alcohol intake histories (alcohol depletes NAD+ significantly)
- People over 45 dealing with cognitive or metabolic decline
- Post-viral patients (long COVID has been associated with NAD+ depletion)
- High-output athletes or executives managing extreme stress loads
If you're 38, sleeping well, eating reasonably well, and generally functional — oral NMN is probably a reasonable low-risk investment. IV NAD+ is probably not your first move.
The Bottom Line
NAD+ is not hype. The science is real, the cellular mechanisms are well-documented, and the clinical applications are growing. But the delivery method matters enormously, the marketing overpromises, and it works best in a broader optimization framework — not as a standalone intervention.
If you want to understand your actual NAD+ status and whether optimization makes sense for your specific situation, that conversation starts with data.
PracticeRx offers comprehensive cellular health assessments including NAD+ status evaluation and individualized supplementation protocols. Available nationwide.